TGFB1 and neoplasm: Platelet-derived transforming growth factor-β (TGF-β) and platelet-derived growth factor (PDGF) could inhibit natural killer cell (NK) activity, and thus, platelet-covered tumor cells often escape the recognition and the lysis of NK cells.